Literature DB >> 21872856

Blood cell salvage during cesarean delivery.

Justine V Sullivan1, Maria E Crouch, Gary Stocken, Stephen W Lindow.   

Abstract

OBJECTIVE: To review the use of blood cell salvage performed during cesarean delivery.
METHODS: A retrospective review of the case notes of 107 patients who underwent blood cell salvage during cesarean delivery. A total of 102 women at high risk of hemorrhage were prepared preoperatively for cell salvage. A second group of 5 patients had cell salvage initiated intraoperatively owing to unexpected severe hemorrhage.
RESULTS: Of the 107 patients, 36 (33.6%) were re-infused with salvaged blood. There were no reported incidents of amniotic embolization or hemolytic disease. Of the 31 patients for whom cell salvage was prepared preoperatively, only 6 patients required transfusion of banked blood. In elective procedures, patients were re-infused with salvaged blood averaging 28% of the volume of blood lost, without complications.
CONCLUSION: Cell salvage was acceptable, beneficial, and without adverse events in both high-risk elective cesareans and emergency cesareans for unexpected hemorrhaging. The skills refined during use of cell salvage in elective cesareans were crucial for successful implementation during emergency situations.
Copyright © 2011 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21872856     DOI: 10.1016/j.ijgo.2011.06.009

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  2 in total

Review 1.  Does current evidence support the use of intraoperative cell salvage in reducing the need for blood transfusion in caesarean section?

Authors:  Sukhjit K Dhariwal; Khalid S Khan; Shubha Allard; Matthew Wilson; Philip Moore
Journal:  Curr Opin Obstet Gynecol       Date:  2014-12       Impact factor: 1.927

2.  Intraoperative cell salvage for obstetrics: a prospective randomized controlled clinical trial.

Authors:  Ye Liu; Xiaoguang Li; Xiangming Che; Guosheng Zhao; Mingjun Xu
Journal:  BMC Pregnancy Childbirth       Date:  2020-08-07       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.